ABCL-285: CXCR4 Expression as a Determinant of Inferior Outcomes Following CD19 CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis
Year: 2026
Type: article
Study design: Observational Study
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CXCR4, CD19 CAR T-cell therapy, diffuse large B-cell lymphoma, relapsed/refractory lymphoma, CAR T-cell resistance, CXCL12, tumor microenvironment, immune evasion, overall response rate, progression-free survival, relapse, extranodal involvement, bone marrow involvement, prognostic factors, T cell migration
Open Access status: closed
OpenAlex ID: W7204686240
